{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:42:56Z","timestamp":1785220976779,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.steroids.2019.05.002","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T19:38:06Z","timestamp":1557776286000},"page":"114-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["16,17-N\u2032-(alky\/arylsulfonyl)pyrazoline substituted neuroprotective heterosteroids: Synthesis, molecular docking and preclinical efficacy\/toxicity studies in rodents"],"prefix":"10.1016","volume":"148","author":[{"given":"Ranjit","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8448-4887","authenticated-orcid":false,"given":"Ranju","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2019.05.002_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1172\/JCI200317522","article-title":"Neurodegeneration: what is it and where are we?","volume":"111","author":"Przedborski","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2019.05.002_b0010","first-page":"145","article-title":"Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders","volume":"2","author":"Ramanan","year":"2013","journal-title":"Am. J. Neurodegener. Dis."},{"key":"10.1016\/j.steroids.2019.05.002_b0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Bolck","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.steroids.2019.05.002_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer's disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"Sci. World J."},{"key":"10.1016\/j.steroids.2019.05.002_b0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor-Necrosis-Factor-Alpha (Tnf-Alpha) increases both in the brain and in the cerebrospinal-fluid from Parkinsonian-patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.steroids.2019.05.002_b0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.steroids.2019.05.002_b0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.bmc.2005.08.024","article-title":"Synthesis and anti-androgenic activity of some new 3-substituted androstano[17,16-c]-5'-aryl-pyrazoline and their derivatives","volume":"14","author":"Amr","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.steroids.2019.05.002_b0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.steroids.2011.12.012","article-title":"Synthesis of novel D-ring fused 7'-aryl-androstano[17,16-d][1,2,4] triazolo[1,5-a]pyrimidines","volume":"77","author":"Huang","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2019.05.002_b0045","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1016\/j.ejmech.2009.04.020","article-title":"Novel modified steroid derivatives of androstanolone as chemotherapeutic anti-cancer agents","volume":"44","author":"El-Far","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.steroids.2019.05.002_b0050","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/med.21458","article-title":"Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: a literature review","volume":"38","author":"Bansal","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.steroids.2019.05.002_b0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijbiomac.2012.04.012","article-title":"A new investigation for some steroidal derivatives as anti-Alzheimer agents","volume":"51","author":"Abdalla","year":"2012","journal-title":"Int. J. Biol. Macromolec."},{"key":"10.1016\/j.steroids.2019.05.002_b0060","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1021\/acschemneuro.6b00313","article-title":"Investigations on 16-Arylideno steroids as a new class of neuroprotective agents for the treatment of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"8","author":"Singh","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.steroids.2019.05.002_b0065","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1021\/acschemneuro.7b00303","article-title":"Studies on 16,17-pyrazoline substituted heterosteroids as anti-Alzheimer and anti-Parkinsonian agents using LPS induced neuroinflammation models of mice and rats","volume":"9","author":"Singh","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.steroids.2019.05.002_b0070","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2174\/1389557511313060012","article-title":"Pyrazolines: a biological review","volume":"13","author":"Marella","year":"2013","journal-title":"Mini. Rev. Med. Chem."},{"key":"10.1016\/j.steroids.2019.05.002_b0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/13543776.2012.667403","article-title":"Recent advances in the therapeutic applications of pyrazolines","volume":"22","author":"Shaaban","year":"2012","journal-title":"Exp. Opin. Ther. Pat."},{"key":"10.1016\/j.steroids.2019.05.002_b0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.steroids.2014.05.013","article-title":"Synthesis of steroidal derivatives containing substituted, fused and spiro pyrazolines","volume":"87","author":"Romero-Lopez","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2019.05.002_b0085","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1021\/jm200466r","article-title":"N'-(Arylsulfonyl)pyrazoline-1-carboxamidines as novel, neutral 5-hydroxytryptamine 6 receptor (5-HT6R) antagonists with unique structural features","volume":"54","author":"van Loevezijn","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.steroids.2019.05.002_b0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00706-007-0656-8","article-title":"Synthesis, analgesic, and antiparkinsonian profiles of some pyridine, pyrazoline, and thiopyrimidine derivatives","volume":"138","author":"Abdel-Latif","year":"2007","journal-title":"Monatshefte Fur Chem."},{"key":"10.1016\/j.steroids.2019.05.002_b0095","unstructured":"Buccafusco, J., Terry, A., Beach, J.,and Jonnala, R., 2003. Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders. WO 2003008559 A3."},{"key":"10.1016\/j.steroids.2019.05.002_b0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Bio. Chem."},{"key":"10.1016\/j.steroids.2019.05.002_b0105","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmcol."},{"key":"10.1016\/j.steroids.2019.05.002_b0110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","article-title":"Mechanism of lipid peroxide formation in animals","volume":"99","author":"Wills","year":"1965","journal-title":"Biochem. J."},{"key":"10.1016\/j.steroids.2019.05.002_b0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.steroids.2019.05.002_b0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000136485","article-title":"Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite","volume":"11","author":"Jollow","year":"1974","journal-title":"Pharmacology"},{"key":"10.1016\/j.steroids.2019.05.002_b0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","article-title":"Generation of superoxide radical during auto oxidation of hydroxylamine and an assay for superoxide dismutase","volume":"186","author":"Kono","year":"1978","journal-title":"Arch. Biochem. Biophy."},{"key":"10.1016\/j.steroids.2019.05.002_b0130","series-title":"Handbook of Methods for Oxygen Radical Research","first-page":"283","author":"Claiborne","year":"1985"},{"key":"10.1016\/j.steroids.2019.05.002_b0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pbb.2008.12.012","article-title":"Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits","volume":"92","author":"Kuhad","year":"2009","journal-title":"Pharm. Biochem. Behavior."},{"key":"10.1016\/j.steroids.2019.05.002_b0140","unstructured":"http:\/\/www.rcsb.org\/pdb\/explore\/explore.do? Structure ID=2az5 (Accessed on 23\/3\/2016)."},{"key":"10.1016\/j.steroids.2019.05.002_b0145","unstructured":"OECD. Guidelines for the Testing of Chemicals \/Section 4: Health Effects Test No. 423: Acute Oral toxicity \u2013 Acute Toxic Class Method. Organization for Economic Cooperation and Development, Paris, France, 2002."},{"key":"10.1016\/j.steroids.2019.05.002_b0150","unstructured":"OECD. Repeated dose oral toxicity test method. In: OECD Guidelines for testing of chemicals, No 407. Organization for Economic Cooperation and Development, Paris, France, 2008."},{"key":"10.1016\/j.steroids.2019.05.002_b0155","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1081\/DDC-120025458","article-title":"Transfersomes \u2013 a novel vesicular carrier for enhanced transdermal delivery: development characterization and performance evaluation","volume":"29","author":"Jain","year":"2003","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.steroids.2019.05.002_b0160","first-page":"1","article-title":"Molecular mechanisms regulating LPS \u2013 induced inflammation in the brain","volume":"9","author":"Olena","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.steroids.2019.05.002_b0165","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/187152711794653751","article-title":"Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases","volume":"10","author":"Frankola","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.steroids.2019.05.002_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/861231","article-title":"Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity","volume":"2014","author":"Olmos","year":"2014","journal-title":"Mediators Inflamm."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X19300935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X19300935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:03:44Z","timestamp":1758535424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X19300935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":34,"alternative-id":["S0039128X19300935"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2019.05.002","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"16,17-N\u2032-(alky\/arylsulfonyl)pyrazoline substituted neuroprotective heterosteroids: Synthesis, molecular docking and preclinical efficacy\/toxicity studies in rodents","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2019.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}